Summary:
-
Surgery Rates Fall
A new study shows that weight-loss surgery is down by 25.6% as more people turn to anti-obesity medications. -
Rise of Anti-Obesity Drugs
The use of drugs like Ozempic and Wegovy has more than doubled from 2022 to 2023, changing how people manage obesity. -
Study Details
Researchers from Brigham and Womenβs Hospital and Harvard T.H. Chan School of Public Health analyzed data from over 17 million privately insured adults. -
Significant Drug Increase
The study found that the number of patients using GLP-1 receptor agonists grew by 132.6%, indicating a shift toward medication. -
Treatment Gaps
Despite these changes, 94.7% of patients received neither treatment, highlighting a lack of options for many struggling with obesity.
Read more at: Harvard Gazette